Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK: 1335105
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2011-08-12
Last Filing Date: 2025-05-12
SEC Filings
Start End Frame Filed ACCN Value View
2019-01-01 2019-12-31 CY2018 2020-03-25 0001493152-20-004697 $ 67,045,814 View
2020-07-01 2020-09-30 CY2019Q3 2020-11-10 0001493152-20-020918 $ 67,045,814 View
2020-01-01 2020-12-31 CY2019 2021-03-26 0001493152-21-006882 $ 11,277,126 View
2020-04-01 2020-06-30 CY2019Q2 2020-08-10 0001493152-20-015118 $ 67,045,814 View
2021-07-01 2021-09-30 CY2021Q3 2021-11-10 0001493152-21-027755 $ 13,733,912 View
2011-01-01 2011-06-30 CY2011Q2I 2011-08-12 0001144204-11-046091 $ 5,000 View
2011-01-01 2011-09-30 CY2011Q3I 2011-11-10 0001144204-11-062954 $ 5,000 View
2011-01-01 2011-12-31 CY2010 2012-03-29 0001144204-12-018044 $ 5,000 View
2012-01-01 2012-03-31 CY2012Q1 2012-05-10 0001144204-12-027598 $ 33,333 View
2012-01-01 2012-06-30 CY2012Q2I 2012-08-10 0001144204-12-044432 $ 33,333 View
2012-07-01 2012-09-30 CY2011Q3 2012-11-13 0001144204-12-061044 $ 41,558,409 View
2012-01-01 2012-12-31 CY2011 2013-03-15 0001144204-13-015451 $ 38,985,832 View
2013-01-01 2013-03-31 CY2012Q1 2013-05-09 0001144204-13-027401 $ 41,583,097 View
2013-04-01 2013-06-30 CY2012Q2 2013-08-05 0001144204-13-042986 $ 41,583,097 View
2013-07-01 2013-09-30 CY2012Q3 2013-11-07 0001144204-13-059433 $ 41,583,097 View
2013-01-01 2013-12-31 CY2012 2014-03-21 0001144204-14-017092 $ 41,583,097 View
2015-01-01 2015-03-31 CY2014Q1 2015-05-13 0001493152-15-001884 $ 45,497,520 View
2015-04-01 2015-06-30 CY2014Q2 2015-08-07 0001493152-15-003470 $ 46,709,990 View
2015-07-01 2015-09-30 CY2014Q3 2015-11-10 0001493152-15-005286 $ 47,060,597 View
2015-01-01 2015-12-31 CY2014 2016-03-28 0001493152-16-008321 $ 46,793,502 View
2016-01-01 2016-12-31 CY2015 2017-03-29 0001493152-17-002940 $ 47,875,814 View
2017-01-01 2017-03-31 CY2016Q1 2017-05-10 0001493152-17-004949 $ 49,431,370 View
2017-01-01 2017-12-31 CY2016 2018-03-23 0001493152-18-003806 $ 55,817,458 View
2018-07-01 2018-09-30 CY2017Q3 2018-11-08 0001493152-18-015470 $ 58,029,292 View
2018-01-01 2018-12-31 CY2017 2019-03-25 0001493152-19-003870 $ 58,796,115 View
2019-01-01 2019-03-31 CY2018Q1 2019-05-09 0001493152-19-006670 $ 67,045,814 View
2019-04-01 2019-06-30 CY2018Q2 2019-08-06 0001493152-19-011723 $ 67,045,814 View
2019-07-01 2019-09-30 CY2018Q3 2019-11-08 0001493152-19-016669 $ 67,045,814 View
2021-04-01 2021-06-30 CY2021Q2 2021-08-10 0001493152-21-019170 $ 13,633,040 View
2022-01-01 2022-06-30 CY2022Q2 2022-08-10 0001493152-22-021832 $ 0 View
2022-01-01 2022-12-31 CY2022Q4I 2023-03-29 0001493152-23-009386 $ 55,000 View
2014-01-01 2014-03-31 CY2013Q1 2014-05-09 0001493152-14-001385 $ 41,583,097 View
2014-04-01 2014-06-30 CY2013Q2 2014-08-08 0001493152-14-002406 $ 45,018,262 View
2014-07-01 2014-09-30 CY2013Q3 2014-11-12 0001493152-14-003656 $ 45,483,097 View
2014-01-01 2014-12-31 CY2013 2015-03-27 0001493152-15-001047 $ 44,405,563 View
2016-01-01 2016-03-31 CY2015Q1 2016-05-06 0001493152-16-009470 $ 47,875,814 View
2016-04-01 2016-06-30 CY2015Q2 2016-08-10 0001493152-16-012153 $ 47,875,814 View
2016-07-01 2016-09-30 CY2015Q3 2016-11-04 0001493152-16-014500 $ 47,875,814 View
2021-01-01 2021-03-31 CY2021Q1 2021-05-12 0001493152-21-011088 $ 12,768,201 View
2021-07-13 2021-07-14 CY2020 2022-03-21 0001493152-22-007327 $ 83,333 View
2022-01-01 2022-03-31 CY2021Q1 2022-05-11 0001493152-22-012779 $ 13,746,593 View
2022-01-01 2022-09-30 CY2021Q3 2022-11-08 0001493152-22-030878 $ 0 View
2023-01-01 2023-03-31 CY2023Q1 2023-05-10 0001493152-23-016069 $ 519,480 View
2023-04-01 2023-06-30 CY2022Q2 2023-08-09 0001493152-23-027269 $ 1,665,956 View
2023-07-01 2023-09-30 CY2022Q3 2023-11-09 0001493152-23-040115 $ 2,074,938 View
2024-01-01 2024-03-31 CY2024Q1I 2024-05-09 0001493152-24-018337 $ 74,130 View
2024-04-01 2024-06-30 CY2024Q2I 2024-08-08 0001493152-24-030757 $ 49,824 View
2023-01-01 2023-12-31 CY2023Q4I 2024-03-19 0001493152-24-010427 $ 808,365 View
2024-07-01 2024-09-30 CY2024Q3I 2024-11-12 0001493152-24-044810 $ 6,928 View
2024-01-01 2024-12-31 CY2024 2025-03-24 0001641172-25-000208 $ 434,444 View
2025-01-01 2025-03-31 CY2025Q1 2025-05-12 0001641172-25-009575 $ 27,500 View
2017-07-01 2017-09-30 CY2016Q3 2017-11-09 0001493152-17-012642 $ 58,016,031 View
2018-01-01 2018-03-31 CY2017Q1 2018-04-27 0001493152-18-005872 $ 58,025,814 View
2018-04-01 2018-06-30 CY2017Q2 2018-08-02 0001493152-18-010858 $ 58,025,814 View
2017-04-01 2017-06-30 CY2016Q2 2017-08-04 0001493152-17-008520 $ 57,678,012 View
2020-01-01 2020-03-31 CY2019Q1 2020-05-11 0001493152-20-008165 $ 67,045,814 View
SEC Facts By Type
Type Name Description View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value on a recurring basis by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Conversion of Stock, Amount Converted "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Cost of Services, Licenses and Services (Deprecated 2018-01-31) Cost of generating revenue from multiple-deliverable arrangements that include licensing fees and services revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Services revenue may be derived by providing other, nonspecified, services during the reporting period. View
us-gaap Dividends Payable, Current Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Increase (Decrease) in Contract with Customer, Asset Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Money Market Funds, at Carrying Value Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Proceeds from Issuance of Convertible Preferred Stock The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. View
us-gaap Stock Repurchased During Period, Shares Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. View
us-gaap Number of Operating Segments Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. View
us-gaap General Insurance Expense The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales). View
us-gaap APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. View
us-gaap Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction. View
us-gaap Proceeds from Issuance Initial Public Offering The cash inflow associated with the amount received from entity's first offering of stock to the public. View
us-gaap Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) Cumulative net losses reported during the development stage. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
dei Entity Listing, Par Value Per Share The par value per share of security quoted in same currency as Trading currency. Example: '0.01'. View
us-gaap Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Accounts Payable, Related Parties, Current Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accretion Expense Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap Adjustments to Additional Paid in Capital, Other Amount of other increase (decrease) in additional paid in capital (APIC). View
us-gaap APIC, Share-based Payment Arrangement, Recognition and Exercise Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Share-based Payment Arrangement, Expense, after Tax Amount, after tax, of expense for award under share-based payment arrangement. View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Contract with Customer, Liability, Current Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash Acquired from Acquisition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, FDIC Insured Amount The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Class of Warrant or Right, Outstanding Number of warrants or rights outstanding. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Shares Subscribed but Unissued Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Concentration Risk, Percentage "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the ""benchmark"" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." View
us-gaap Contract with Customer, Asset, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Conversion of Stock, Shares Converted "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Convertible Preferred Stock, Shares Issued upon Conversion Number of shares issued for each share of convertible preferred stock that is converted. View
us-gaap Cost of Services (Deprecated 2018-01-31) Total costs related to services rendered by an entity during the reporting period. View
us-gaap Debt Conversion, Converted Instrument, Amount "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Conversion, Converted Instrument, Shares Issued "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or payments in the period." View
us-gaap Debt Instrument, Periodic Payment Amount of the required periodic payments including both interest and principal payments. View
us-gaap Deferred Compensation Arrangement with Individual, Compensation Expense The compensation expense recognized during the period pertaining to the deferred compensation arrangement. View
us-gaap Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements payable after one year (or the operating cycle, if longer). View
us-gaap Deferred Costs, Noncurrent Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, Domestic Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, Foreign Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, State and Local Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards, Research Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from contingent liabilities. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Deposits Assets, Current Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Depreciation, Nonproduction The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives. View
us-gaap Dividends, Preferred Stock Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). View
us-gaap Dividends, Preferred Stock, Stock Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock. View
us-gaap Due to Officers or Stockholders, Current Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Due to Officers or Stockholders Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement. View
us-gaap Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for option under share-based payment arrangement. View
us-gaap Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability. View
us-gaap Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) Agreed upon price for the exchange of the underlying asset. View
us-gaap Foreign Currency Transaction Gain (Loss), before Tax Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Grants Receivable Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. View
us-gaap Grants Receivable, Current Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. View
us-gaap Income Taxes Paid The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Increase (Decrease) in Accrued Interest Receivable, Net The increase (decrease) during the reporting period in the amount due from borrowers for interest payments. View
us-gaap Proceeds from Contributed Capital The cash inflow associated with the amount received by a corporation from a shareholder during the period. View
us-gaap Increase (Decrease) in Contract with Customer, Liability Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. View
us-gaap Increase (Decrease) in Deposit Assets The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expenses, Other Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. View
us-gaap Increase (Decrease) in Prepaid Insurance Amount of increase (decrease) of consideration paid in advance for insurance that provides economic benefits in future periods. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Paid, Including Capitalized Interest, Operating and Investing Activities Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. View
us-gaap Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. View
us-gaap Interest Receivable, Current Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. View
us-gaap Investment Income, Nonoperating The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations. View
us-gaap Legal Fees The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities Assumed The fair value of liabilities assumed in noncash investing or financing activities. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Licenses Revenue (Deprecated 2018-01-31) Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. View
us-gaap Marketable Securities, Unrealized Gain (Loss) Amount of unrealized gain (loss) on investment in marketable security. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. View
us-gaap Salary and Wage, Officer, Excluding Cost of Good and Service Sold Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Other Cost and Expense, Operating The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. View
us-gaap Payments for Merger Related Costs The amount of cash paid during the reporting period for charges associated with the mergers. View
us-gaap Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period. View
us-gaap Payments for Repurchase of Convertible Preferred Stock The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury. View
us-gaap Payments of Ordinary Dividends, Preferred Stock and Preference Stock Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity. View
us-gaap Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security. View
us-gaap Payments to Acquire Machinery and Equipment The cash outflow for acquisition of machinery and equipment. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Redemption Amount The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable Amount of subscription receivable from investors who have been allocated nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. View
us-gaap Prepaid Expense, Noncurrent Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. View
us-gaap Prepaid Insurance Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. View
us-gaap Proceeds from Issuance of Warrants The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). View
us-gaap Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. View
us-gaap Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. View
us-gaap Proceeds from (Repayments of) Restricted Cash, Financing Activities The net cash inflow or outflow from cash and cash items that are not available for withdrawal or usage. View
us-gaap Proceeds from Sale and Maturity of Marketable Securities The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Proceeds from Stock Plans The cash inflow associated with the amount received from the stock plan during the period. View
us-gaap Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants. View
us-gaap Registration Payment Arrangement, Gains and Losses The decrease (gain) or increase (loss) in the carrying amount of the registration payment obligation that was recognized in earnings during the period. View
us-gaap Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party. View
us-gaap Repayments of Convertible Debt The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Repayments of Debt The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Sale of Stock, Consideration Received on Transaction Cash received on stock transaction after deduction of issuance costs. View
us-gaap Sale of Stock, Number of Shares Issued in Transaction The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. View
us-gaap Sale of Stock, Price Per Share Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Shares Issued, Price Per Share Per share or per unit amount of equity securities issued. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum The maximum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Net number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares Number of non-vested options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Number of options vested. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Acquisitions Value of stock issued pursuant to acquisitions during the period. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other. View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Stock or Unit Option Plan Expense Amount of noncash expense for option under share-based payment arrangement. View
us-gaap Stock Repurchased During Period, Value Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. View
us-gaap Unrecognized Tax Benefits Amount of unrecognized tax benefits. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Contractual Obligation Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. View
us-gaap Payment of Financing and Stock Issuance Costs The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities. View
us-gaap Related Party Costs Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Compensation Expense, Excluding Cost of Good and Service Sold Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Percentage of vesting of award under share-based payment arrangement. View
us-gaap Management Fee Payable Carrying amount of the unpaid portion of the fee payable to the managing member or general partner for management of the fund or trust. View
us-gaap Other Commitment Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Deferred Tax Assets, in Process Research and Development Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. View
us-gaap Foreign Currency Exchange Rate, Translation Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency. View
us-gaap Number of Reportable Segments Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. View
us-gaap Other Prepaid Expense, Current Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Number of equity instruments other than options outstanding, including both vested and non-vested instruments. View
us-gaap Deferred Offering Costs Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. View
Chart of Accounts => Accounts
Name View
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Compensation Expense, Excluding Cost of Good and Service Sold View
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage View
General Insurance Expense View
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition View
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction View
Prepaid Expense, Current View
Prepaid Expense View
Prepaid Expense, Noncurrent View
Prepaid Insurance View
Proceeds from Contributed Capital View
Proceeds from Issuance Initial Public Offering View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Convertible Preferred Stock View
Proceeds from Issuance of Preferred Stock and Preference Stock View
Proceeds from Issuance of Warrants View
Proceeds from Issuance or Sale of Equity View
Proceeds from Related Party Debt View
Proceeds from (Repayments of) Restricted Cash, Financing Activities View
Proceeds from Sale and Maturity of Marketable Securities View
Proceeds from Stock Options Exercised View
Proceeds from Stock Plans View
Proceeds from Warrant Exercises View
Registration Payment Arrangement, Gains and Losses View
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party View
Repayments of Convertible Debt View
Repayments of Debt View
Research and Development Expense View
Retained Earnings (Accumulated Deficit) View
Revenues View
Sale of Stock, Consideration Received on Transaction View
Sale of Stock, Number of Shares Issued in Transaction View
Sale of Stock, Price Per Share View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price View
Accounts Payable and Accrued Liabilities, Current View
Accounts Payable, Related Parties, Current View
Accretion Expense View
Additional Paid in Capital View
Additional Paid in Capital, Common Stock View
Adjustments to Additional Paid in Capital, Other View
APIC, Share-based Payment Arrangement, Recognition and Exercise View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Share-based Payment Arrangement, Expense View
Share-based Payment Arrangement, Expense, after Tax View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Assets View
Assets, Current View
Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) View
Cash View
Cash Acquired from Acquisition View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Cash, FDIC Insured Amount View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Class of Warrant or Right, Outstanding View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Shares Subscribed but Unissued View
Common Stock, Value, Issued View
Concentration Risk, Percentage View
Contract with Customer, Asset, after Allowance for Credit Loss, Current View
Contract with Customer, Liability, Current View
Conversion of Stock, Amount Converted View
Conversion of Stock, Shares Converted View
Convertible Preferred Stock, Shares Issued upon Conversion View
Cost of Services (Deprecated 2018-01-31) View
Cost of Services, Licenses and Services (Deprecated 2018-01-31) View
Debt Conversion, Converted Instrument, Amount View
Debt Conversion, Converted Instrument, Shares Issued View
Debt Instrument, Periodic Payment View
Deferred Compensation Arrangement with Individual, Compensation Expense View
Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent View
Deferred Costs, Noncurrent View
Deferred Tax Assets, Gross View
Deferred Tax Assets, Net of Valuation Allowance View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Operating Loss Carryforwards, Domestic View
Deferred Tax Assets, Operating Loss Carryforwards, Foreign View
Deferred Tax Assets, Operating Loss Carryforwards, State and Local View
Deferred Tax Assets, Tax Credit Carryforwards, Research View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies View
Deferred Tax Assets, Valuation Allowance View
Deposits Assets, Current View
Depreciation View
Depreciation, Nonproduction View
Weighted Average Number of Shares Outstanding, Basic View
Dividends Payable, Current View
Dividends, Preferred Stock View
Dividends, Preferred Stock, Stock View
Due to Officers or Stockholders, Current View
Due to Officers or Stockholders View
Earnings Per Share, Basic and Diluted View
Effective Income Tax Rate Reconciliation, Percent View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent View
Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount View
Fair Value Adjustment of Warrants View
Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) View
Foreign Currency Transaction Gain (Loss), before Tax View
General and Administrative Expense View
Grants Receivable View
Grants Receivable, Current View
Income Taxes Paid View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Accrued Interest Receivable, Net View
Increase (Decrease) in Contract with Customer, Asset View
Increase (Decrease) in Contract with Customer, Liability View
Increase (Decrease) in Deposit Assets View
Increase (Decrease) in Prepaid Expense and Other Assets View
Increase (Decrease) in Prepaid Expenses, Other View
Increase (Decrease) in Prepaid Insurance View
Interest Expense View
Interest Paid, Including Capitalized Interest, Operating and Investing Activities View
Interest Paid, Excluding Capitalized Interest, Operating Activities View
Interest Receivable, Current View
Investment Income, Nonoperating View
Legal Fees View
Liabilities View
Liabilities and Equity View
Liabilities Assumed View
Liabilities, Current View
Licenses Revenue (Deprecated 2018-01-31) View
Marketable Securities, Unrealized Gain (Loss) View
Money Market Funds, at Carrying Value View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Income (Loss) Attributable to Parent View
Net Income (Loss) Available to Common Stockholders, Basic View
Salary and Wage, Officer, Excluding Cost of Good and Service Sold View
Operating Expenses View
Operating Income (Loss) View
Operating Loss Carryforwards View
Other Cost and Expense, Operating View
Payments for Merger Related Costs View
Payments for Repurchase of Common Stock View
Payments for Repurchase of Convertible Preferred Stock View
Payments of Ordinary Dividends, Preferred Stock and Preference Stock View
Payments of Stock Issuance Costs View
Payments to Acquire Machinery and Equipment View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Redemption Amount View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable View
Preferred Stock, Value, Issued View
Prepaid Expense and Other Assets, Current View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable View
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares View
Share Price View
Shares, Outstanding View
Stockholders' Equity Attributable to Parent View
Stock Issued During Period, Shares, New Issues View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Acquisitions View
Stock Issued During Period, Value, Issued for Services View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Other View
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture View
Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture View
Stock Issued During Period, Value, Stock Options Exercised View
Stock or Unit Option Plan Expense View
Stock Repurchased During Period, Value View
Unrecognized Tax Benefits View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Contractual Obligation View
Payment of Financing and Stock Issuance Costs View
Related Party Costs View
Shares Issued, Price Per Share View
Stock Repurchased During Period, Shares View
Earnings Per Share, Basic View
Management Fee Payable View
Other Commitment View
Accounts Payable, Current View
Cost of Revenue View
Earnings Per Share, Diluted View
Weighted Average Number of Shares Outstanding, Diluted View
Deferred Tax Assets, in Process Research and Development View
Foreign Currency Exchange Rate, Translation View
Number of Operating Segments View
Number of Reportable Segments View
Other Prepaid Expense, Current View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number View
Deferred Offering Costs View